Broad Spectrum Analysis of 109 Priority Compounds Listed in the 76/464/CEE Council Directive Using Solid-Phase Extraction and GC/EI/MS

2000 ◽  
Vol 72 (7) ◽  
pp. 1430-1440 ◽  
Author(s):  
Sílvia Lacorte ◽  
Ingrid Guiffard ◽  
Daniel Fraisse ◽  
Damià Barceló
1997 ◽  
Vol 43 (11) ◽  
pp. 2099-2105 ◽  
Author(s):  
David M Steinberg ◽  
Lori J Sokoll ◽  
Kathy C Bowles ◽  
James H Nichols ◽  
Roger Roberts ◽  
...  

Abstract A prototype Toxi · Prep (TP) system that utilizes solid-phase extraction (SPE) has been developed as a method for broad-spectrum drug screening and identification of tetrahydrocannabinol (THC) metabolites in urine. TP can simultaneously extract up to seven specimens while automating the process of sample extraction, washing, and elution onto a chromatogram. TP was compared with the Toxi · Lab A (TL-A) system for extraction of basic drugs only. In a blind study, 33 distinct drugs and metabolites were detected in 55 urines over 13 runs. Of the drug occurrences, 68.8% (141 of 205) were detected on both TP and TL-A. Of the 13 runs, quinidine and quinine, nortriptyline metabolites, and diphenhydramine were noted more frequently on TP than TL-A, whereas nicotine and metabolites, morphine, and methadone metabolites were more frequently noted on TL-A. Twenty specimens were analyzed for THC metabolites. Of the cases positive for THC metabolites, 100% (16 of 16) were positive by both methods. Time and motion studies for all runs proved an overall labor reduction for extraction and spotting by ∼40%.


Sign in / Sign up

Export Citation Format

Share Document